Importance
Neurocognition is a central characteristic of schizophrenia and other psychotic disorders. Identifying the pattern and severity of neurocognitive functioning during the “near-psychotic”, prodromal, clinical high-risk (CHR) state is necessary to develop accurate predictors of psychosis and more effective and potentially preventative treatments.
Objective
Identify core neurocognitive dysfunctions associated with the CHR phase, and measure the ability of neurocognitive tests to predict the transition to psychosis. Determine if the neurocognitive deficits are robust or explained by potential confounders.
Design
Case control study. Baseline neurocognitive functioning collected from 2008–2012 in the second phase of the North American Prodrome Longitudinal Study (NAPLS-2).
Setting
A consortium of eight university-based, outpatient programs studying the psychosis prodrome in North America.
Participants
CHR individuals (n=689) and healthy controls (HCs, n=264) consisting of 137 male and 127 female HC and 398 male and 291 female CHR individuals ages 12–35.
Interventions or Exposures
A naturalistic, observational study.
Main Outcome and Measure(s)
Neurocognitive differences between those who did and did not transition to psychosis, differences between medicated and unmedicated groups, and time to conversion. Nineteen neuropsychological tests and four factors derived from factor analysis.
Results
The factors were Executive Function/Visual-Spatial, Verbal, Attention/Working Memory, and Declarative Memory. Amongst widespread mild to moderate impairments, CHR individuals were significantly impaired compared to HCs on Attention/Working Memory and Declarative Memory. CHR converters had large Declarative Memory and Attention/Working Memory deficits (Cohen’s d = ~0.8, p <.001) compared with controls and were significantly worse on these dimensions than non-converters. In Cox regression, impaired Declarative Memory and high Verbal (premorbid) ability in addition to age, site and positive psychotic symptoms, significantly predicted time to conversion in those who later transitioned to psychosis. The pattern of impairments could not be accounted for by premorbid or current general cognitive ability, medications, current depression, alcohol or cannabis abuse.
Conclusions and Relevance
Neurocognitive impairment is a robust characteristic of CHR individuals, especially those who later develop psychosis. Tests tapping verbal and visual declarative memory and attention/working memory were most sensitive to imminent psychosis amongst those at CHR. Interventions targeting the enhancement of neurocognitive functioning are warranted in this population.